Mannkind reported $-11409000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Biocryst Pharmaceuticals BCRX:US USD -17445000 17.28M
Eli Lilly And LLY:US USD 1.95B 294.9M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Immunogen IMGN:US USD -77429000 16.38M
Insmed INSM:US USD -122459000 21.52M
JAZZ PHA JAZZ:US USD 199.21M 72.86M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Macrogenics MGNX:US USD -24955000 16.85M
Mannkind MNKD:US USD -11409000 13.55M
Merk MRK:US USD 5.56B 156M
Minerva Neurosciences NERV:US USD -5207150 1.76M
Novo Nordisk A Fs NVO:US DKK 20.18B 1.79B
Peregrine Pharmaceuticals PPHM:US USD 2.74M 1.67M
Pfizer PFE:US USD 9.7B 2.43B
Xencor XNCR:US USD -38348000 10.35M